Cardio Historical Income Statement

CDIOW Stock  USD 0.04  0.0001  0.24%   
Historical analysis of Cardio Diagnostics income statement accounts such as Depreciation And Amortization of 117.2 K, Selling General Administrative of 7.3 M or Selling And Marketing Expenses of 99 K can show how well Cardio Diagnostics Holdings performed in making a profits. Evaluating Cardio Diagnostics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Cardio Diagnostics's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Cardio Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cardio Diagnostics is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

About Cardio Income Statement Analysis

Cardio Diagnostics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cardio Diagnostics shareholders. The income statement also shows Cardio investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Cardio Diagnostics Income Statement Chart

At this time, Cardio Diagnostics' Selling General Administrative is fairly stable compared to the past year. Total Revenue is likely to climb to about 17.9 K in 2024, despite the fact that Operating Income is likely to grow to (6.9 M).

Total Revenue

Total revenue comprises all receipts Cardio Diagnostics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Cardio Diagnostics. It is also known as Cardio Diagnostics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Cardio Diagnostics income statement and is an important metric when analyzing Cardio Diagnostics profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.
Most accounts from Cardio Diagnostics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Cardio Diagnostics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
At this time, Cardio Diagnostics' Selling General Administrative is fairly stable compared to the past year. Total Revenue is likely to climb to about 17.9 K in 2024, despite the fact that Operating Income is likely to grow to (6.9 M).
 2021 2023 2024 (projected)
Reconciled Depreciation16K53.8K56.5K
Total Operating Expenses621.3K7.3M7.6M

Cardio Diagnostics income statement Correlations

0.930.770.93-0.92-0.95-0.280.98-0.250.931.0-0.94-1.0-0.94-0.990.850.95
0.930.831.0-1.0-1.0-0.620.96-0.61.00.94-1.0-0.94-1.0-0.960.990.87
0.770.830.84-0.85-0.84-0.570.86-0.550.840.81-0.85-0.78-0.85-0.80.840.78
0.931.00.84-1.0-1.0-0.620.96-0.591.00.94-1.0-0.94-1.0-0.960.990.87
-0.92-1.0-0.85-1.01.00.64-0.960.61-1.0-0.931.00.941.00.95-0.99-0.88
-0.95-1.0-0.84-1.01.00.56-0.970.53-1.0-0.961.00.961.00.98-0.97-0.91
-0.28-0.62-0.57-0.620.640.56-0.421.0-0.62-0.330.60.320.60.37-0.74-0.23
0.980.960.860.96-0.96-0.97-0.42-0.390.960.99-0.97-0.98-0.97-0.990.910.92
-0.25-0.6-0.55-0.590.610.531.0-0.39-0.59-0.30.570.290.570.34-0.72-0.2
0.931.00.841.0-1.0-1.0-0.620.96-0.590.94-1.0-0.94-1.0-0.960.990.87
1.00.940.810.94-0.93-0.96-0.330.99-0.30.94-0.95-0.99-0.95-0.990.870.94
-0.94-1.0-0.85-1.01.01.00.6-0.970.57-1.0-0.950.951.00.97-0.98-0.9
-1.0-0.94-0.78-0.940.940.960.32-0.980.29-0.94-0.990.950.951.0-0.87-0.96
-0.94-1.0-0.85-1.01.01.00.6-0.970.57-1.0-0.951.00.950.97-0.98-0.9
-0.99-0.96-0.8-0.960.950.980.37-0.990.34-0.96-0.990.971.00.97-0.9-0.96
0.850.990.840.99-0.99-0.97-0.740.91-0.720.990.87-0.98-0.87-0.98-0.90.79
0.950.870.780.87-0.88-0.91-0.230.92-0.20.870.94-0.9-0.96-0.9-0.960.79
Click cells to compare fundamentals

Cardio Diagnostics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardio Stock Analysis

When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.